Cerebras Systems Inc.

424B4 priced

Price $185.00 · 30,000,000 shares · Gross proceeds $5,419,575,000

Cerebras Systems Inc. filed a 424B4 prospectus for its IPO, detailing lock-up periods, share release schedules, and risks. Key elements include 171.1 million shares expected to be released from lock-up, dilution for new investors, use of proceeds, increased public company costs, no dividend policy, and market volatility risks. The filing also highlights anti-takeover provisions and challenges related to analyst coverage and index inclusion.

EFFECT effective

CERT inactive

8-A12B effective

Cerebras Systems Inc. is registering its Class A common stock for listing on the Nasdaq Stock Market LLC under the symbol 'CBRS'. The filing references the previously filed S-1 registration statement, confirming the initial public offering (IPO) details, including the anticipated share price range and underwriter arrangements. The company emphasizes its AI infrastructure technology and highlights its transition to a public entity.

S-1/A amended

Range $150.00 to $160.00 · 30,000,000 shares

Cerebras Systems Inc. is conducting its initial public offering (IPO) by registering 30,000,000 shares of Class A common stock, with an anticipated price range of $150.00 to $160.00 per share. The offering is contingent on listing on the Nasdaq Global Select Market under the symbol 'CBRS.' The company emphasizes its wafer-scale AI infrastructure, including the WSE-3 chip, and highlights its unique architecture optimized for AI workloads. The filing also outlines the post-offering capital structure, including three classes of common stock with distinct voting and conversion rights.

S-1/A amended

Range $115.00 to $125.00 · 28,000,000 shares

Cerebras Systems Inc. is conducting its initial public offering (IPO) by registering 28,000,000 shares of Class A common stock, with an expected price range of $115.00 to $125.00 per share. The offering is contingent on the stock being listed on the Nasdaq Global Select Market under the ticker 'CBRS.' The company has three classes of authorized stock, with Class A shares carrying voting rights. Cerebras emphasizes its wafer-scale AI infrastructure and positions itself as an emerging growth company under U.S. securities laws.

S-1 filed

Cerebras Systems Inc. is conducting its initial public offering (IPO) of Class A common stock, with shares anticipated to be listed on the Nasdaq Global Select Market under the symbol 'CBRS.' The company, an emerging growth company, has structured its capital with three classes of stock (Class A, B, and N), each with distinct voting and conversion rights. The filing highlights the company's focus on wafer-scale integration for AI workloads, a technical innovation developed over a decade. The IPO follows years of R&D and commercialization efforts, with the company emphasizing its proprietary architecture to address AI's communication-bound computational challenges.

DRS/A amended

Cerebras Systems Inc. filed an amended draft registration statement (DRS/A) for its initial public offering (IPO), confirming the offering of Class A common stock with an anticipated price range. The filing highlights the company's transition to a three-class stock structure (Class A, B, N) and outlines underwriting details, including a directed share program for select investors. The IPO remains contingent on Nasdaq listing approval, with Morgan Stanley, Citigroup, and other firms listed as underwriters. The company emphasizes its status as an emerging growth company and includes a 'Risk Factors' section warning of market and operational uncertainties.

DRS filed

Cerebras Systems Inc. has submitted a confidential DRS filing for its initial public offering (IPO), resuming its IPO process after previously withdrawing an S-1 registration in October 2025. The company plans to offer Class A common stock, with underwriters including Morgan Stanley, Citigroup, and Barclays. The filing highlights its emerging growth company status, describes its AI chip technology, and outlines risks related to market competition and reliance on key personnel. The IPO is contingent on Nasdaq listing approval.

RW withdrawn

Cerebras Systems Inc. has requested the withdrawal of its previously filed Registration Statement on Form S-1 for an upcoming initial public offering (IPO). The company stated it no longer intends to proceed with the offering at this time.

S-1 filed

Cerebras Systems Inc. is conducting its initial public offering (IPO) of Class A common stock, with shares expected to be listed on the Nasdaq Global Market under the symbol 'CBRS.' The offering includes 12.5 million shares sold by the company and an additional 1.5 million shares from selling stockholders. The company plans to use proceeds for general corporate purposes, including expanding its AI chip manufacturing capabilities and research and development. The filing highlights the company's emerging growth status and includes a 'Risk Factors' section detailing potential investment risks.

DRS/A amended

Cerebras Systems Inc. is preparing for its initial public offering (IPO) with an expected price range of $X to $Y per share, selling 1,000,000 shares. The company, an emerging growth company, plans to list on the [Exchange] under the ticker 'CBRS.' Underwriters include Citigroup, Barclays, UBS Investment Bank, and others. The filing highlights risks related to market acceptance, financial performance, and regulatory changes.

DRS/A amended

Cerebras Systems Inc. has submitted a confidential draft registration statement (DRS/A) for its initial public offering (IPO), outlining plans to offer common stock with an expected price range and underwriter support. The filing highlights the company's status as an emerging growth company, emphasizing reduced reporting requirements. Key sections include risk factors, underwriting details, and a prospectus summary, though financial data for certain periods is omitted pending amendment.

DRS filed

Cerebras Systems Inc. is conducting its initial public offering (IPO) of common stock, with no existing public market for its shares. The company plans to sell shares at an expected price range of $ to $ per share, with underwriters holding an option for over-allotments. The offering is underwritten by Citigroup and Barclays, and the stock is expected to be listed on an exchange under the symbol 'CEREB.' The company has elected to comply with reduced reporting requirements as an emerging growth company.